ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System

Beth Fand Incollingo
on: May 24, 2022In: Evolving Standards of Care, Meeting News
Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System

A presentation at the 2022 European Lung Cancer Congress convinced attendees that the current system for staging lung cancer needs refinement. Read more


As Treatment Options in Lung Cancer Have Expanded, so Have Costs

Giulia Pasello, MD, PhD
+more
on: May 11, 2022In: Evolving Standards of Care, Patient Advocacy
As Treatment Options in Lung Cancer Have Expanded, so Have Costs

A real-world look at diagnostic-therapeutic pathways explores how they may help provide optimal, innovative care without ballooning costs. Read more

Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis

Alvaro Quintanal-Villalonga, PhD
+more
on: May 11, 2022In: Evolving Standards of Care
Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis

In the search to understand the mechanisms of metastasis, researchers have expanded the spectrum of SCLC clinical specimens amenable for single-cell resolution analysis. Read more

COAST Data Support Further Research of Immunotherapy Combinations

Mariona Riudavets, MD, PhD
+more
on: May 11, 2022In: Evolving Standards of Care
COAST Data Support Further Research of Immunotherapy Combinations

Trial is the first to show improved efficacy and a manageable safety profile after cCRT in unresectable locally advanced stage III NSCLC regardless of PD-L1 status. Read more

TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

Joy Curzio
on: April 26, 2022In: Evolving Standards of Care
TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

Dr. Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. Read more

Early Palliative Care: A European Perspective

Florian Scotté, MD, PhD
on: April 26, 2022In: Evolving Standards of Care
Early Palliative Care: A European Perspective

The benefits of early palliative care have been proven. Could negative connotations of palliative care be impeding its adoption? Read more

Tumor Growth Rate as a Guide for Precision Lung Cancer Therapy

Mizuki Nishino, MD, MPH
+more
on: April 12, 2022In: Evolving Standards of Care
Tumor Growth Rate as a Guide for Precision Lung Cancer Therapy

The speed at which a tumor progresses may prove to be a useful tool in therapeutic decision-making. Read more

Patient Perspective: The Promise of Personalized Medicine

Angus Pratt, MBA
on: April 12, 2022In: Evolving Standards of Care, Patient Advocacy
Patient Perspective: The Promise of Personalized Medicine

Growing treatment options for patients with late-stage lung cancer bring hope—and challenges. Read more

Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

Skyler B. Johnson, MD
on: April 12, 2022In: Evolving Standards of Care, Patient Advocacy
Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

Inaccurate health information can have grave consequences, but there are techniques providers can use to combat it. Read more

A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC

Ticiana Leal, MD
+more
on: April 12, 2022In: Evolving Standards of Care
A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC

The strategy likely will not be pursued, however studies of PARP inhibitors plus immune checkpoint inhibitors are already in advanced stages. Read more

‹123456›»
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy